Загрузка...
Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
BACKGROUND/AIMS: Rabbit anti-thymocyte globulin (ATG) is usually incorporated in hematopoietic stem cell transplantation (HSCT) to reduce the incidence of graft-versus-host disease (GVHD). This study aimed to find optimal ATG doses in patients undergoing human leukocyte antigen (HLA)-mismatched allo...
Сохранить в:
| Опубликовано в: : | Korean J Intern Med |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Association of Internal Medicine
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7061010/ https://ncbi.nlm.nih.gov/pubmed/30616303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2018.317 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|